Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that new Phase 1 data for IPI-549, an orally administered immuno-oncology development candidate that selectively inhibits...

Viavi Solutions Inc. (NASDAQ: VIAV) today announced its latest suite of innovative accessories to the MicroNIR family of products. The accessories work in conjunction with the MicroNIR Pro, which...

Simon, a global leader in retail real estate, today announced that members of senior management will provide an overview of the Company's business to the investment community at the Citi 2017...

Nearly 150 advocates from six kidney organizations around the country will converge on Capitol Hill, March 6-7, 2017, to meet personally with lawmakers and put a human face on kidney disease...

Rebiotix Inc., a clinical-stage biotechnology company focused on harnessing the power of the human microbiome to treat challenging diseases, today announced that it will participate in two...